651 related articles for article (PubMed ID: 29571724)
1. Puerarin prevents LPS-induced acute lung injury via inhibiting inflammatory response.
Wang X; Yan J; Xu X; Duan C; Xie Z; Su Z; Ma H; Ma H; Wei X; Du X
Microb Pathog; 2018 May; 118():170-176. PubMed ID: 29571724
[TBL] [Abstract][Full Text] [Related]
2. Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.
Qiushi W; Guanghua L; Guangquan X
Eur J Pharmacol; 2015 Mar; 750():32-8. PubMed ID: 25620130
[TBL] [Abstract][Full Text] [Related]
3. Chikusetsusaponin V attenuates lipopolysaccharide-induced acute lung injury in mice by modulation of the NF-κB and LXRα.
Su K; Zhang G; Zhang X; Jiang W
Int Immunopharmacol; 2019 May; 70():174-179. PubMed ID: 30807930
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
[TBL] [Abstract][Full Text] [Related]
5. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
Jing W; Chunhua M; Shumin W
Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
[TBL] [Abstract][Full Text] [Related]
6. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
[TBL] [Abstract][Full Text] [Related]
7. Nobiletin-Ameliorated Lipopolysaccharide-Induced Inflammation in Acute Lung Injury by Suppression of NF-κB Pathway In Vivo and Vitro.
Li W; Zhao R; Wang X; Liu F; Zhao J; Yao Q; Zhi W; He Z; Niu X
Inflammation; 2018 Jun; 41(3):996-1007. PubMed ID: 29541888
[TBL] [Abstract][Full Text] [Related]
8. Isoalantolactone protects LPS-induced acute lung injury through Nrf2 activation.
Yuan CB; Tian L; Yang B; Zhou HY
Microb Pathog; 2018 Oct; 123():213-218. PubMed ID: 30009971
[TBL] [Abstract][Full Text] [Related]
9. Glycitin alleviates lipopolysaccharide-induced acute lung injury via inhibiting NF-κB and MAPKs pathway activation in mice.
Chen Y; Guo S; Jiang K; Wang Y; Yang M; Guo M
Int Immunopharmacol; 2019 Oct; 75():105749. PubMed ID: 31306981
[TBL] [Abstract][Full Text] [Related]
10. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
[TBL] [Abstract][Full Text] [Related]
11. Dihydrotanshinone Attenuates LPS-Induced Acute Lung Injury in Mice by Upregulating LXRα.
Yue J; Su K; Zhang G; Yang J; Xu C; Liu X
Inflammation; 2022 Feb; 45(1):212-221. PubMed ID: 34467464
[TBL] [Abstract][Full Text] [Related]
12. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
Du ZA; Sun MN; Hu ZS
Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
[TBL] [Abstract][Full Text] [Related]
14. Effects of alliin on LPS-induced acute lung injury by activating PPARγ.
Wang YL; Guo XY; He W; Chen RJ; Zhuang R
Microb Pathog; 2017 Sep; 110():375-379. PubMed ID: 28711511
[TBL] [Abstract][Full Text] [Related]
15. Necrostatin-1 attenuates lipopolysaccharide-induced acute lung injury in mice.
Guan E; Wang Y; Wang C; Zhang R; Zhao Y; Hong J
Exp Lung Res; 2017; 43(9-10):378-387. PubMed ID: 29199874
[TBL] [Abstract][Full Text] [Related]
16. Puerarin prevents vascular endothelial injury through suppression of NF-κB activation in LPS-challenged human umbilical vein endothelial cells.
Deng HF; Wang S; Li L; Zhou Q; Guo WB; Wang XL; Liu MD; Liu K; Xiao XZ
Biomed Pharmacother; 2018 Aug; 104():261-267. PubMed ID: 29775893
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
[TBL] [Abstract][Full Text] [Related]
18. Syringic acid attenuates acute lung injury by modulating macrophage polarization in LPS-induced mice.
Wang WT; Zhang YY; Li ZR; Li JM; Deng HS; Li YY; Yang HY; Lau CC; Yao YJ; Pan HD; Liu L; Xie Y; Zhou H
Phytomedicine; 2024 Jul; 129():155591. PubMed ID: 38692075
[TBL] [Abstract][Full Text] [Related]
19. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
[TBL] [Abstract][Full Text] [Related]
20. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
